An mHealth intervention to improve medication adherence among patients with coronary heart disease in China: Development of an intervention

Zhao Ni, Changqing Liu, Bei Wu, Qing Yang, Christian Douglas, Ryan Jeffrey Shaw

Research output: Contribution to journalArticle

Abstract

Objectives: With this study, we aimed to develop a mobile technology (mHealth) intervention to improve medication adherence among patients with coronary heart disease (CHD). Methods: The study was conducted in two phases with CHD patients from a Cardiology Department of a hospital located in China. Each phase was independent from the other. Phase 1 tested the integration of the two apps — “WeChat” and “BB Reminder” — as an mHealth intervention. All participants received the same educational materials via WeChat every two days. Participants in the experimental group received a reminder from BB Reminder for every dose of their medications. The duration of Phase 1 was 30 days for each participant. Phase 2 refined the intervention, in which educational materials were sent every five days rather than every two days, and medication-taking reminders were sent daily rather than every dose. Results: In Phase 1, an mHealth intervention was developed by integrating two mobile apps. In Phase 2, medication adherence increased at 30-day follow-up in both groups compared to baseline. At the 30-day follow-up, the mean of the decrease in medication non-adherence score in the experimental group (M = −1.35, SD = 2.18, n = 36) was more than the decrease in control group (M = −0.69, SD = 1.58, n = 36), which means the medication adherence improved more in the experimental group. Conclusion: The feasibility of using mHealth to remind CHD patients to take their medications is high.

Original languageEnglish (US)
Pages (from-to)322-330
Number of pages9
JournalInternational Journal of Nursing Sciences
Volume5
Issue number4
DOIs
StatePublished - Oct 10 2018

Fingerprint

Medication Adherence
Telemedicine
Coronary Disease
China
Mobile Applications
Hospital Departments
Cardiology
Technology
Control Groups

Keywords

  • China
  • Coronary disease
  • Medication adherence
  • mHealth
  • Mobile applications

ASJC Scopus subject areas

  • Nursing(all)

Cite this

An mHealth intervention to improve medication adherence among patients with coronary heart disease in China : Development of an intervention. / Ni, Zhao; Liu, Changqing; Wu, Bei; Yang, Qing; Douglas, Christian; Shaw, Ryan Jeffrey.

In: International Journal of Nursing Sciences, Vol. 5, No. 4, 10.10.2018, p. 322-330.

Research output: Contribution to journalArticle

@article{7cbd488d66324225881c3b18bb7bb36b,
title = "An mHealth intervention to improve medication adherence among patients with coronary heart disease in China: Development of an intervention",
abstract = "Objectives: With this study, we aimed to develop a mobile technology (mHealth) intervention to improve medication adherence among patients with coronary heart disease (CHD). Methods: The study was conducted in two phases with CHD patients from a Cardiology Department of a hospital located in China. Each phase was independent from the other. Phase 1 tested the integration of the two apps — “WeChat” and “BB Reminder” — as an mHealth intervention. All participants received the same educational materials via WeChat every two days. Participants in the experimental group received a reminder from BB Reminder for every dose of their medications. The duration of Phase 1 was 30 days for each participant. Phase 2 refined the intervention, in which educational materials were sent every five days rather than every two days, and medication-taking reminders were sent daily rather than every dose. Results: In Phase 1, an mHealth intervention was developed by integrating two mobile apps. In Phase 2, medication adherence increased at 30-day follow-up in both groups compared to baseline. At the 30-day follow-up, the mean of the decrease in medication non-adherence score in the experimental group (M = −1.35, SD = 2.18, n = 36) was more than the decrease in control group (M = −0.69, SD = 1.58, n = 36), which means the medication adherence improved more in the experimental group. Conclusion: The feasibility of using mHealth to remind CHD patients to take their medications is high.",
keywords = "China, Coronary disease, Medication adherence, mHealth, Mobile applications",
author = "Zhao Ni and Changqing Liu and Bei Wu and Qing Yang and Christian Douglas and Shaw, {Ryan Jeffrey}",
year = "2018",
month = "10",
day = "10",
doi = "10.1016/j.ijnss.2018.09.003",
language = "English (US)",
volume = "5",
pages = "322--330",
journal = "International Journal of Nursing Sciences",
issn = "2352-0132",
publisher = "Elsevier (Singapore) Pte Ltd",
number = "4",

}

TY - JOUR

T1 - An mHealth intervention to improve medication adherence among patients with coronary heart disease in China

T2 - Development of an intervention

AU - Ni, Zhao

AU - Liu, Changqing

AU - Wu, Bei

AU - Yang, Qing

AU - Douglas, Christian

AU - Shaw, Ryan Jeffrey

PY - 2018/10/10

Y1 - 2018/10/10

N2 - Objectives: With this study, we aimed to develop a mobile technology (mHealth) intervention to improve medication adherence among patients with coronary heart disease (CHD). Methods: The study was conducted in two phases with CHD patients from a Cardiology Department of a hospital located in China. Each phase was independent from the other. Phase 1 tested the integration of the two apps — “WeChat” and “BB Reminder” — as an mHealth intervention. All participants received the same educational materials via WeChat every two days. Participants in the experimental group received a reminder from BB Reminder for every dose of their medications. The duration of Phase 1 was 30 days for each participant. Phase 2 refined the intervention, in which educational materials were sent every five days rather than every two days, and medication-taking reminders were sent daily rather than every dose. Results: In Phase 1, an mHealth intervention was developed by integrating two mobile apps. In Phase 2, medication adherence increased at 30-day follow-up in both groups compared to baseline. At the 30-day follow-up, the mean of the decrease in medication non-adherence score in the experimental group (M = −1.35, SD = 2.18, n = 36) was more than the decrease in control group (M = −0.69, SD = 1.58, n = 36), which means the medication adherence improved more in the experimental group. Conclusion: The feasibility of using mHealth to remind CHD patients to take their medications is high.

AB - Objectives: With this study, we aimed to develop a mobile technology (mHealth) intervention to improve medication adherence among patients with coronary heart disease (CHD). Methods: The study was conducted in two phases with CHD patients from a Cardiology Department of a hospital located in China. Each phase was independent from the other. Phase 1 tested the integration of the two apps — “WeChat” and “BB Reminder” — as an mHealth intervention. All participants received the same educational materials via WeChat every two days. Participants in the experimental group received a reminder from BB Reminder for every dose of their medications. The duration of Phase 1 was 30 days for each participant. Phase 2 refined the intervention, in which educational materials were sent every five days rather than every two days, and medication-taking reminders were sent daily rather than every dose. Results: In Phase 1, an mHealth intervention was developed by integrating two mobile apps. In Phase 2, medication adherence increased at 30-day follow-up in both groups compared to baseline. At the 30-day follow-up, the mean of the decrease in medication non-adherence score in the experimental group (M = −1.35, SD = 2.18, n = 36) was more than the decrease in control group (M = −0.69, SD = 1.58, n = 36), which means the medication adherence improved more in the experimental group. Conclusion: The feasibility of using mHealth to remind CHD patients to take their medications is high.

KW - China

KW - Coronary disease

KW - Medication adherence

KW - mHealth

KW - Mobile applications

UR - http://www.scopus.com/inward/record.url?scp=85054864835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054864835&partnerID=8YFLogxK

U2 - 10.1016/j.ijnss.2018.09.003

DO - 10.1016/j.ijnss.2018.09.003

M3 - Article

AN - SCOPUS:85054864835

VL - 5

SP - 322

EP - 330

JO - International Journal of Nursing Sciences

JF - International Journal of Nursing Sciences

SN - 2352-0132

IS - 4

ER -